DILLARDS INC-CL A
DDSNYSE🏆 #702 by market capUS Equity
$91.23▲ $7.38 (+8.09%)
Simulated price1h—
24h▲ 8.1%
7d—
14d—
30d—
1y—
🏦Market Cap
$10.09B
Mid Cap
📈Revenue Growth (YoY)
-7.0%
Declining
📊Gross Margin
40.5%
Healthy
💵FCF Margin
11.4%
Healthy
⚖️P/S Ratio
1.5x
Cheap
Otter Score
67
Fair
No chart data available for DDS.
Trading Snapshot
- Day Range
- $89.85 – $91.78
- 52-Week Range
- $456.69 – $741.98
- Volume
- $4.14B
- Avg Volume
- $4.71B
- Shares Outstanding
- 15.6M
- Next Earnings
- Sep 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $6.81B
- Last Q Revenue
- $1.74B
- P/E Ratio
- 14.9
- P/S Ratio
- 1.5x
- EPS (TTM)
- $42.07
- Dividend Yield
- 4.96%
Why Investors Own DDS
- ✓High-growth profile — revenue up +39.6% YoY with expanding US Equity exposure.
- ✓Healthy economics — 46% gross margin and 12% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$6.81B▲ +34.0% YoY
Gross Margin (TTM)
45.5%▲ +3.2% YoY
Operating Income (TTM)
$1.57B▲ +34.0% YoY
Free Cash Flow (TTM)
$790M▲ +34.0% YoY
About DILLARDS INC-CL A
A company profile for DILLARDS INC-CL A isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
67/100
Analyst Price Target
ⓘAverage Target
$105.61
▲ +15.8% Upside
High Target$130.39
Low Target$78.33
Based on 12 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
DILLARDS INC-CL A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift DDS price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
DILLARDS INC-CL A announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.